SEC Form 4 · accession 0001055726-17-000032
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B. Weiner
Director
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2017 | S | 8,000 | $8.002 | D | 740,956 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.